Skip to content
lifestyle.luxedb.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Avalyn Pharma Inc.
Avalyn Pharma: AP01 Lung Distribution & Patient Trial Data for Pulmonary Fibrosis
September 8, 2026
Avalyn Pharma to Present at Morgan Stanley Healthcare Conference
September 8, 2026
Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026
August 24, 2026
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
June 17, 2026
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
May 5, 2026
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 1, 2026
Avalyn Announces Pricing of Upsized Initial Public Offering
April 29, 2026
Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury
April 27, 2026
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
April 6, 2026
1
2
Next Page
→